Advanced Medical Solutions Group (CHIX:AMSL) Liabilities-to-Assets : 0.34 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:AMSL Advanced Medical Solutions Group PLC CHIX:AMSL
81 GF Score
Price £2.80
GF Value £3.73
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Advanced Medical Solutions Group Liabilities-to-Assets?

Advanced Medical Solutions Group CHIX:AMSL -0.18% 81 Liabilities-to-Assets is 0.34 as of Dec. 2025. GuruFocus rates CHIX:AMSL with a GF Score™ of 81/100 and a GF Value™ of £3.73 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Advanced Medical Solutions Group's Total Liabilities for the quarter that ended in Dec. 2025 was £134.7 Mil. Advanced Medical Solutions Group's Total Assets for the quarter that ended in Dec. 2025 was £394.8 Mil. Therefore, Advanced Medical Solutions Group's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2025 was 0.34.


Advanced Medical Solutions Group  (CHIX:AMSl) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Advanced Medical Solutions Group Liabilities-to-Assets Related Terms


Advanced Medical Solutions Group Liabilities-to-Assets Historical Data

* Premium members only.

The historical data trend for Advanced Medical Solutions Group's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Medical Solutions Group Liabilities-to-Assets Chart

Advanced Medical Solutions Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.16 0.16 0.38 0.34

Advanced Medical Solutions Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.34 0.38 0.35 0.34

CHIX:AMSL vs ISRG, BDX, MDLN: Liabilities-to-Assets Comparison

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group Liabilities-to-Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's Liabilities-to-Assets falls into.


CHIX:AMSL
81GF Score
Advanced Medical Solutions Group PLC CHIX:AMSL
Liabilities-to-Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Medical Solutions Group Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Advanced Medical Solutions Group's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2025 is calculated as:

Liabilities-to-Assets (A: Dec. 2025 )=Total Liabilities/Total Assets
=134.666/394.77
=0.34

Advanced Medical Solutions Group's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2025 is calculated as

Liabilities-to-Assets (Q: Dec. 2025 )=Total Liabilities/Total Assets
=134.666/394.77
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Liabilities-to-Assets →
What does a Liabilities-to-Assets of 0.34 mean?
Advanced Medical Solutions Group (CHIX:AMSL) has a Liabilities-to-Assets of 0.34 as of Dec. 2025. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Advanced Medical Solutions Group and its competitors.
Is Advanced Medical Solutions Group's Liabilities-to-Assets too high?
Advanced Medical Solutions Group's current Liabilities-to-Assets is 0.34. Overall, Advanced Medical Solutions Group has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Liabilities-to-Assets compare to ISRG and BDX?
Advanced Medical Solutions Group's Liabilities-to-Assets of 0.34 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Medical Devices & Instruments company?
A good Liabilities-to-Assets depends on the Medical Devices & Instruments industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Advanced Medical Solutions Group and its competitors. Advanced Medical Solutions Group's current Liabilities-to-Assets is 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.73, compared to a current price of £2.80 — trading 24.9% below its estimated fair value. The current Liabilities-to-Assets is 0.34. Advanced Medical Solutions Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Liabilities-to-Assets is 0.34 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued. The current stock price of £2.80 is trading 24.9% below its estimated GF Value™ of £3.73. GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.

Key valuation signals for CHIX:AMSL:

  • Liabilities-to-Assets: 0.34
  • GF Value™: £3.73 vs. price of £2.80 (24.9% below fair value)
  • GF Score™: 81/100 with 8 warning signs

No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advanced Medical Solutions Group Business Description

Other Exchanges AMS:UKAQA:Germany
Address Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
81GF Score

Get the complete analysis for CHIX:AMSL

Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.80
Price
£3.73
GF Value